"We still have a lot to learn," Stephen Rose, chief research officer for the Foundation Fighting Blindness, told the AARP Bulletin. "But it's not a question of if we'll end blindness. It's really just a question of when."
New treatments offer hope to the millions of mostly older Americans in danger of losing their sight from macular degeneration, glaucoma, diabetic retinopathy and other eye diseases.
Read the full story: